Many diabetes treatments also impact weight loss and obesity medication such as GLP-1 agonists, combined with healthy lifestyle interventions, can positively impact morbidities associated with diabetes and obesity.1 Patients with Type 2 diabetes have diminished responses of incretin hormones compared to healthy individuals
without diabetes, according to an analysis by Komodo Health, a health information technology company
(2019) Selective persulfide detection reveals evolutionarily conserved antiaging effects of S-sulfhydration
Key exclusion criteria included other medications impacting weight, unstable medical illness, active substance use disorder, and dual antipsychotic use
Potential side effects: Researchers have observed mild nausea, flushing, headache, and transient blood pressure changes